Cargando…
Bisphenol A at Low Nanomolar Doses Confers Chemoresistance in Estrogen Receptor-α–Positive and –Negative Breast Cancer Cells
BACKGROUND: Resistance to chemotherapy is a major problem facing breast cancer patients, and identifying potential contributors to chemoresistance is a critical area of research. Bisphenol A (BPA) has long been suspected to promote carcinogenesis, but the high doses of BPA used in many studies gener...
Autores principales: | LaPensee, Elizabeth W., Tuttle, Traci R., Fox, Sejal R., Ben-Jonathan, Nira |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649216/ https://www.ncbi.nlm.nih.gov/pubmed/19270784 http://dx.doi.org/10.1289/ehp.11788 |
Ejemplares similares
-
Analysis of a Prescription Drug Prior Authorization Program in a Medicaid Health Maintenance Organization
por: LaPensee, Kenneth
Publicado: (2003) -
The Estrogen-Related Receptor α Inverse Agonist
XCT 790 Is a Nanomolar Mitochondrial Uncoupler
por: Eskiocak, Banu, et al.
Publicado: (2014) -
1462. Hospital Admission Patterns in Adult Patients with Community-Acquired Bacterial Pneumonia Who Received Ceftriaxone and a Macrolide by Pneumonia Severity Index Score
por: Lodise, Thomas, et al.
Publicado: (2018) -
Placental Lactogen Is Expressed but Is Not Translated into Protein in Breast Cancer
por: Tuttle, Traci R., et al.
Publicado: (2014) -
Differential Estrogenic Actions of Endocrine-Disrupting Chemicals Bisphenol A, Bisphenol AF, and Zearalenone through Estrogen Receptor α and β in Vitro
por: Li, Yin, et al.
Publicado: (2012)